TSLA stock intra day -3.35%. See our team note short of before and after chart Noted of short under $280 and target $275 and $270, so far today's lows at $269.50 intra-day 2/15 note as we took short via puts intra day 2/16 stock is down -3.25% as writing this blog. Target achieved.
I've been a trader and investor for the biotechnology sector for many years, the unconfirmed "speculation buyout rumors" spreading around wall street are a norm these days. Basically, everyone thinks their stock is a buyout candidate, but these buyout rumors tend to be false and once in a while it's true. The rumors [...]
These are chart and notes share to members ahead of the breakout this week. All generate profits. Feb 10, part of Sunday trade plan Feb 10, Sunday trade plan Tuesday 2/14 trade plan
Notable Hedgefund Q4 2016 filings: Pershing Square Exits ZTS stake, Increases CMG Reduced VRX, APD, and PAH. Top holdings RBI CMG MDLZ and APD. Paulson & Co. Exits TMUS, GRFS, VNDA, HUM, MAR New buys INSW, TIME, GOOG, WDAY, GSK. Increases DXCM, THM, LOXO, PFE and MELI. Reduced AIG, SHPG, AGN, TEVA, GLD and MYL. Omega Advisor New [...]
SPY 1 year anniversary from 2016 bottom. From oversold to overbought.
**Sign -up on our FREE daily newsletter of Morning Briefing, Market Recap + Educational Chart set-up, to get this directly in your email, please make sure to add our email address in your contact list, to ensure that it will get directly in your inbox, some email server directs our newsletter in Spam or Promotion [...]
Puma Biotechnology (PBYI) +12.85% intra-day on social media speculation of buyout from GILD TESARO Inc, (TSRO) +11.92% Reuters reports of takeover approaces IBB biotech index -0.06% We do not know if these are true or not, they are still speculation until it's finalized Charts:
BIDU we have been swinging this trade since last week. See our chart notes as we locked in profits today
***Not recommendation to buy or sell, these are my opinion and idea only. Always do your own due diligence and consult your financial adviser before investing/trading.*** SCYX (+9.21%) to $3.44, company have Rare Disease Conference today and live RBC Presentation on Wed, Feb 22,http://ir.scynexis.com/releasedetail.cfm?ReleaseID=1009778 These are my five bullish reason from blog on [...]
AKAO +8% follow analyst upgraded this morning with price target at $27 ESPR +14.61% intra-day, third days running after AMGN cholesterol drug result IBB -0.14% biotech sector overall stalled Chart for educational only